Published 2020-09-25
license
Article (before OJS)

MOLECULAR DIAGNOSIS OF SARS-CoV-2

DOI: https://doi.org/10.22490/24629448.4184

Authors

Gladys Pinilla Universidad Colegio Mayor de Cundinamarca
Claudia Andrea Cruz B Universidad Colegio Mayor de Cundinamarca
Jeannette Navarrete O Universidad Colegio Mayor de Cundinamarca.

COVID-19 diagnosis is based on both clinical aspects and screening tests. However, clinical symptoms and signs in infected patients are highly atypical; hence, molecular tests are essential for diagnosis. RT-qPCR is carried out at BSL II level laboratories; the main molecular targets for viral detection are E gene (envelope), and RdRP gene (RNA-dependent RNA polymerase). False negatives in this diagnosis are due to sample quality and quantity, transport conditions, storage and handling before and after extraction (RNA is heat-labile and RNases are abundant); infection phase; virus mutations and presence of CRP inhibitors. Taking into account analytical sensitivity of RT-qPCR (5.2 copies of RNA / reaction) and the fact that once RNA it is extracted, it progressively degrades and affects test diagnostic sensitivity, a new sample -specifically taken from the lower respiratory tract in order to increase viral load- is recommended in the abovementioned cases. Timely diagnosis allows optimizing management (isolation and treatment), patient monitoring, implementing prevention and control measures as well as epidemiological surveillance of the disease

keywords: diagnosis, RT qPCR, SARS virus, coronavirus
license

How to Cite

Pinilla , G., Cruz B, C. A., & Navarrete O, J. (2020). MOLECULAR DIAGNOSIS OF SARS-CoV-2. NOVA Biomedical Sciences Journal, 18(35), 35-41. https://doi.org/10.22490/24629448.4184
Almétricas